Showing results (121-130 of 269) with videos related to

Sort By:
Pageof 27
Plos One|March 27, 2014
Effect of intraoperative high-dose remifentanil on postoperative pain: a prospective, double blind, randomized clinical trialYan-Ling Zhang, Peng Ou, Xiang-Hang Lu, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|March 18, 2016
[Design method of constitution regulating and healthcare foods based on medicinal property combination mode]Fang Dong, Su-rong Yan, Li Ma, et al.
Micron (Oxford, England : 1993)|December 3, 2014
Non-rigid landmark-based large-scale image registration in 3-D reconstruction of mouse and rat kidney nephronsYan-Ling Zhang, Shi-Jie Chang, Xiao-Yue Zhai, et al.
Steroids|September 18, 2016
Solvent-free synthesis of novel steroidal 2-aminopyridinesYan-Ling Zhang, Ya-Fei Li, Xiao-Li Shi, et al.
Molecular Neurobiology|September 10, 2020
Early-Life Multiple Sevoflurane Exposures Alleviate Long-term Anxiety-Like Behaviors in Mice via the proBDNF/ERK PathwayRu-Yi Luo, Cong Luo, Feng Zhong, et al.
Biology Methods & Protocols|January 28, 2022
In vitro fluorescence assay to measure GDP/GTP exchange of guanine nucleotide exchange factors of Rho family GTPasesAlyssa M Blaise, Ellen E Corcoran, Eve S Wattenberg, et al.
Neuropharmacology|May 2, 2021
Early-life sevoflurane exposure impairs fear memory by suppressing extracellular signal-regulated kinase signaling in the bed nucleus of stria terminalis GABAergic neuronsXiao-Pei Zhao, Feng Zhong, Ru-Yi Luo, et al.
Plos One|October 1, 2009
Timosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stressFrank W King, Sylvia Fong, Chandi Griffin, et al.
Age (Dordrecht, Netherlands)|July 20, 2010
Pro12Ala polymorphism in PPAR-gamma2 and dementia in Chinese nonagenarians/centenariansJi-Rong Yue, Bi-Rong Dong, Chang-Quan Huang, et al.
Journal of Clinical Pharmacology|March 23, 2010
Randomized, double-blind, placebo-controlled, single intravenous dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of the novel coronary smooth muscle cell proliferation inhibitor Biolimus A9 in healthy individualsWolfgang Steudel, Colleen Dingmann, Yan-Ling Zhang, et al.
Pageof 27